Navigating Medical Insurance Delays and Denials: Insights from Patients, ASTRO and the Press

Navigating medical insurance for radiation treatment in the United States is frustrating and complex, often resulting in disappointment for patients, delays in care, and denials of standard of care treatment.

Practical Elements of a Radiopharmaceutical Program: Findings from ASTRO's Safety White Paper

Despite the rapid advancements, there exists a gap in the integration of radiopharmaceutical therapy within radiation oncology practices.

Is Consolidation Radiotherapy Still Needed for Lymphoma in 2024? Reappraisal in Light of Recent Trials Results

Radiotherapy plays an important role as a consolidation treatment after systemic therapy, either to shorten the course of systemic therapy and reduce hematological, cardiac and fertility toxicity or to reduce the risk of relapse e.g., for bulky masses.

At the Cutting Edge: The Increasing Role of Salvage Radiotherapy in Relapsed/Refractory Lymphomas

Recently, there have been exciting advances in the treatment of relapsed/refractory (R/R) lymphomas. Historically, the standard-of-care included salvage chemotherapy followed by autologous stem cell transplantation (ASCT). Today, many other salvage options are available.

Beyond Counting on Our Fingers: The Current State and Future Management of Oligometastatic Lung Cancer

There is a high degree of variability in the management and even the understanding of the oligometastatic state in lung malignancies, or indeed in the context of any solid tumor.

Relevant or Relegated? Radiotherapy for Stage III NSCLC in the Neoadjuvant Era

There are many ongoing advances in the multidisciplinary management of stage III NSCLC, in particular the advent of neoadjuvant immunotherapy in patients who are resectable.

Hypofractionation for Soft Tissue Sarcoma

Modern trends throughout radiation oncology have favored short-course hypofractionated regimens which are frequently more cost-effective and convenient for patients. Over the past two years, multiple prospective studies have emerged supporting hypofractionation in soft tissue sarcoma.

How Sentinel Lymph Node Biopsy is Impacting Adjuvant Radiation Treatment in Gynecologic Cancers

There is increasing use of sentinel lymph node biopsy in gynecologic cancers but how best to integrate this information into post-operative radiation treatment recommendations is not always clear. This includes how to interpret isolated tumor cells, micrometastasis, and macrometastasis.

Pitfalls, Perils and Pearls: Identifying and Managing Gynecologic Treatment Toxicity

The introduction of novel therapies for gynecologic malignancies such as immunotherapy, SBRT and complex brachytherapy can lead to increased frequency of severe toxicities for which treatment options may be limited.

Update on ASTRO's Partial Breast Irradiation Guidelines: Case-based Discussion

Breast cancer is the most diagnosed cancer in women. The most commonly diagnosed form of breast cancer in the United States is early-stage breast cancer, for which there are outstanding outcomes.

Pages

Subscribe to RSS - Sessions onDemand